Now playing
01:00
Cancer: The facts
Fox News/Twitter
Now playing
01:33
ADL wants Fox News to fire Tucker Carlson over racist comments
CNN
Now playing
02:36
The truth behind Covid-19 vaccines for sale on the dark web
Now playing
04:22
Levi's CEO has message for Mitch McConnell
Now playing
01:54
'You think I'm racist': Former Fox News host storms off camera
Korie Robertson and Willie Robertson of the reality series "Duck Dynasty" attend the Capitol File 58th Presidential Inauguration Reception at Fiola Mare on January 19, 2017 in Washington, DC.
Paul Morigi/Getty Images
Korie Robertson and Willie Robertson of the reality series "Duck Dynasty" attend the Capitol File 58th Presidential Inauguration Reception at Fiola Mare on January 19, 2017 in Washington, DC.
Now playing
01:46
'Duck Dynasty' stars discuss raising biracial son on new show
FOX/"The Masked Singer"
Now playing
01:24
Nick Cannon makes big splash in 'Masked Singer' return
The Drew Barrymore Show/YouTube
Now playing
01:26
'Mom' star speaks out about not having kids in real life
Heinz ketchup packets are shown in New York on Monday, August 22, 2005. H.J. Heinz Co., the world's biggest ketchup maker, said first-quarter profit fell 19 percent on expenses to cut jobs and sell businesses.  (Photo by Andrew Harrer/Bloomberg via Getty Images)
Andrew Harrer/Bloomberg/Getty Images
Heinz ketchup packets are shown in New York on Monday, August 22, 2005. H.J. Heinz Co., the world's biggest ketchup maker, said first-quarter profit fell 19 percent on expenses to cut jobs and sell businesses. (Photo by Andrew Harrer/Bloomberg via Getty Images)
Now playing
01:53
Restaurants face a nationwide ketchup packet shortage
Camerota Berman both
CNN
Camerota Berman both
Now playing
02:33
CNN anchor Alisyn Camerota gets surprise tribute from co-anchor
Citigroup Chairman Richard Parsons delivers remarks on the US economy at the New York State Bar Association meetings in New York, January 28, 2009. Troubled US banking giant Citigroup last week named Parsons as its new chairman, the longtime top executive at media giant Time Warner, to steer it through its most challenging period.  AFP PHOTO / Emmanuel Dunand (Photo credit should read EMMANUEL DUNAND/AFP via Getty Images)
EMMANUEL DUNAND/AFP/AFP via Getty Images
Citigroup Chairman Richard Parsons delivers remarks on the US economy at the New York State Bar Association meetings in New York, January 28, 2009. Troubled US banking giant Citigroup last week named Parsons as its new chairman, the longtime top executive at media giant Time Warner, to steer it through its most challenging period. AFP PHOTO / Emmanuel Dunand (Photo credit should read EMMANUEL DUNAND/AFP via Getty Images)
Now playing
02:47
Dick Parsons: Georgia law is a bald-faced attempt to suppress Black vote
Courtesy of Warner Bros. Picture
Now playing
02:54
'Godzilla vs. Kong' is a pandemic box office hit
Now playing
01:30
5 ways to cut your plastic waste
CNN/Getty Images
Now playing
04:40
Stelter: After elevating Gaetz, Fox News barely covering scandal
NASA/Goddard/University of Arizona
Now playing
01:08
See NASA spacecraft successfully land on an asteroid
Now playing
06:51
Alisyn Camerota's kids wish her good luck in new role on CNN

Story highlights

Ovarian cancer is one of the most lethal types of cancer

Men who are carriers of the gene have an increased risk of other types of cancer

(CNN) —  

A previously unrecognized link has been found between ovarian cancer and a gene on the X chromosome, according to a new study.

The finding, which reveals that a father’s genes play an important role in a woman’s ovarian cancer risk, could change the way doctors look for and treat one of the most lethal types of cancer.

The gene, called MAGEC3, is still under investigation by scientists. A normal version is thought to be protective against tumor formation, according to the study, which was published last week in the journal PLOS Genetics. However, mutations may result in the unrestrained growth and reproduction of cells, leading to cancer.

Ovarian cancer has a five-year survival rate of approximately 45%, according to the American Cancer Society. In 2015, there were about 1.5 million cases of ovarian cancer worldwide and more than 161,000 deaths, making it the eighth most common cause of death from cancer.

“Ovarian cancer is sometimes called the silent killer. It’s hard to detect, and it’s hard to predict,” said Kevin Eng, an associate professor of oncology at the Roswell Park Comprehensive Cancer Center and a leading author of the study.

The study identified the gene by comparing more than 3,000 grandmother/granddaughter pairs from the Familial Ovarian Cancer Registry at the Roswell Park Cancer Institute in Buffalo, New York.

Founded in 1981, the registry contains more than 50,000 participants from more than 2,600 families with a history of ovarian cancer.

“Our study really leveraged this large familial registry that we’ve had running at Roswell Park for over 35 years,” Eng said. “The familial cancer registry is, I believe, the oldest ovarian cancer registry in the world.”

Eng and his colleagues theorized that, because women have two X chromosomes but men have only one, a mutated gene on the X chromosome would be shared twice as often between paternal grandmother/granddaughter pairs than maternal pairs.

The authors of the study “really thought outside the box,” according to Dr. Krishnansu Tewari, a professor of obstetrics and gynecology and interim director of the Division of Gynecologic Oncology at the University of California, Irvine, who was not involved in the research.

“If the problem is on the X (chromosome) and the sisters are all affected but the mom isn’t, that means it’s coming from the dad, and originally it came from an affected grandmother on the paternal side,” Tewari said.

CNN

The researchers found that women whose paternal grandmothers had ovarian cancer were twice as likely to develop ovarian cancer themselves, compared with those whose maternal grandmothers had ovarian cancer – consistent with the theory that the responsible gene was on the X chromosome.

Overall, 28.4% of the granddaughters in the paternal pairs also developed ovarian cancer, compared with 13.9% of the granddaughters in the maternal pairs.

Notoriously hard to diagnose

The results of the new study may provide valuable insight into one of the most difficult cancers to identify and diagnose at a treatable stage, according to Tewari.

“Ovarian cancer doesn’t have any specific early symptoms,” he said. “It’s the most lethal gynecologic cancer because there’s a paucity of early symptoms and absence of a validated screening test.”

Screening tests include vaginal ultrasound or a blood test that looks for CA-125, a protein that is often elevated in patients with ovarian cancer. However, these tests typically detect only advanced cases and have a high false positive rate, meaning many people with a positive test do not actually have cancer.

“When symptoms manifest, they are often indicative of advanced disease: bloating, abdominal and pelvic discomfort, sometimes pelvic pain, difficulty with the bowels, pressure on the bladder,” Tewari said.

“All those symptoms are nonspecific symptoms that really reflect advanced disease.”

Due to the advanced nature of most ovarian cancer cases, treatment typically includes aggressive surgery and heavy doses of chemotherapy, according to Tewari.

“The cornerstone of treatment is aggressive cytoreductive surgery – what we call surgical debulking, where you cut out all the tumor in order to leave the patient with as little residual disease as possible,” he said. “This sets the stage for chemotherapy.

“That said, the 10-year disease-free survival is still under 10%,” he added. “That is why it is so important for patients to voluntarily enroll into clinical trials that are testing new, promising drugs.”

Looking beyond first-degree relatives

The study’s findings could change the way doctors perform family histories for gynecologic cancers, according to Tewari.

“I think it’s definitely going to have an immediate impact on how we take family histories and how much importance we place on second-degree relatives such as a paternal grandmother,” he said.

“Whenever we talk about genetic testing, we’re usually so focused on the first-degree relatives – the mother, the daughter, the sister – and we always think of the grandmother as a second-degree relative,” Tewari added. “But in this case, a paternal grandmother could be very critical.”

Before this study, the BRCA1 and BRCA2 genes were the ones most commonly associated with ovarian cancer, accounting for around 15% of all ovarian cancer cases, according to Tewari. However, these genes are located on autosomes – i.e. not the X or Y chromosome – and follow a different inheritance pattern than genes on the X chromosome.

“If a father has a mutation on chromosome 3 and the mother doesn’t, there’s only a 50% chance for each child to inherit a bad chromosome 3,” Tewari continued. “But if the father’s one X chromosome has a mutation, then all of his daughters will inherit that bad X chromosome because the father determines the sex of the child.”

Eng said that “the weird thing about this pattern is also that Dad will always pass on the same X chromosome to all of his daughters. So unlike BRCA, you have this all-or-nothing pattern, so you and every one of your sisters is going to have the same X chromosome from dad.”

Individuals with the mutated gene on the X chromosome also developed ovarian cancer at a surprisingly young age, according to Eng.

“The median age of onset for ovarian cancer is 65, but for the early-onset ones, we’re talking about women getting cancer earlier than 45,” he said.

Men who carry the gene may still be at risk

Men who carried the mutated gene were also not in the clear, the researchers found. Though men cannot develop ovarian cancer, those with the mutation were significantly more likely to develop other types of cancer, particularly prostate cancer, according to Eng.

“To some extent, we did see a bump in prostate cancers for the intervening dad,” Eng said. “This suggests that there could be other cancers that are caused by this particular gene.”

Follow CNN Health on Facebook and Twitter

  • See the latest news and share your comments with CNN Health on Facebook and Twitter.

What this means for the future diagnosis and treatment of ovarian cancer is still unclear, Tewari says.

“I think that part of the study is very preliminary at this point,” he said.

“Once the putative gene is validated, we can sequence it, we can clone it, we can test for it, and we can potentially save many women from ovarian cancer and some men from prostate cancer,” Tewari added. “The exact number of lives saved will really depend on what percentage of presumably sporadic cases of ovarian cancer are indeed X-linked.”

According to Eng, knowing your family history is still among the best ways to identify your risk for ovarian cancer. “One of the best preventative measures is talking with your family, knowing if you have a family history of ovarian cancer and communicating that to your primary care physician,” he said.